About Second Heart
Second Heart is a Healthcare company based in Salt Lake City (United States) founded in 2015 by Jeff Donofrio and Howard Leonhardt. A minimally invasive circulatory support platform. Second Heart has raised $33.98 million across 3 funding rounds from investors including Patel Property Investments. Its chief executive, as recorded, is Jeff Donofrio. Second Heart offers products and services including Whisper and Freedom. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is Second Heart Assist Inc. Its competitors include CVRx, HeartWare and Element Science; 3 of its 3 listed competitors have raised funding.
Company details
Second Heart was founded in 2015 in Salt Lake City, United States, within the medical device sector focused on cardiovascular care. A proprietary aortic stent pump technology is utilized to create a circulatory support platform, deployed through low-profile catheter-based methods. An initial temporary assist pump is targeted for acute decompensated heart failure patients and high-risk percutaneous coronary interventions. A subsequent wirelessly powered device is intended for chronic heart failure support.
- Headquarters Salt Lake City, United States
- Founders Jeff Donofrio, Howard Leonhardt
- SectorsHealthcare
- Phone•••• ••••
- Website secondheartinc.com
- Legal Name Second Heart Assist Inc
- Total Equity Funding$33.98M (USD)
in 3 rounds
- Latest Funding Round$14.67M (USD), Series C
Dec 2021
- Investors
Products & Services of Second Heart
Second Heart offers a comprehensive portfolio of products and services, including Whisper and Freedom.
Provides mechanical circulatory support for heart failure patients in clinical trials.
Offers chronic heart support through wireless technology for improved function.
Funding Insights of Second Heart
Second Heart has successfully raised a total of $33.98M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $14.67 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $33.98M
- Total Rounds 3
- Last Round Series C — $14.67M
- First Round $18.3M
(Dec 2016)
- Investors Count 1
All 3 funding rounds of Second Heart with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $14.67M | Series C | – | – | – |
| Nov 2017 | $1M | Series A | – | Patel Investment | – |
| Dec 2016 | $18.3M | Series B | – | – | – |
1 investors in total: 1 institutional.
Investors in Second Heart
Second Heart has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Patel Property Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A real estate investment enterprise focused on property deals. | patelinvestment.com | Newport, United States |
Investor details for Second Heart
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Second Heart
22 people are tracked at Second Heart (12 in leadership, 4 in board & advisors, 6 in team).
| Name | Role | Group |
|---|---|---|
Jeff Donofrio | Co-Founder & CEO | Leadership |
Howard Leonhardt | Co-Founder | Leadership |
Howard J. Leonhardt | CEO | Leadership |
Stuart Kozlick | Chief Operating Officer | Leadership |
Leslie Miller | Chief Medical Officer | Leadership |
Alex Richardson | Chief Technology Officer & VP, Engineering & Product Development | Leadership |
Dinesh Patel | Chief Advisor Business Development | Leadership |
Mark Cunningham | Chief Advisor Cardio, Thoracic Surgery | Leadership |
Samer Banihani | Chief Nephrologist Kidney Health Advisor | Leadership |
Ben Boytor | Chief Advisor, Quality Management Systems | Leadership |
Bruce Methven | Assistant to the President | Leadership |
Anthony Domenici | Contract Chief Financial Advisor & Accounts Payable Team Leader | Leadership |
Mark Libratore | Board Director | Board & advisors |
Patrick Griffith | Senior Advisor, CardioThoracic Surgery | Board & advisors |
Robyn Thornburgh | Board Advisor & Candidate Board Director | Board & advisors |
Bill Carpou | Board Member | Board & advisors |
Tim Henry | Senior Interventional Cardiology Advisor | Team |
Peter Mcbride | Senior Business Development Advisor | Team |
Zvonmir Krajcer | Senior Interventional Cardiology Advisor | Team |
Nicolas Chronos | Senior Interventional Cardiology Advisor | Team |
2 more people are available in the full profile.
Complete people profiles for Second Heart
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Second Heart
3 dated milestones of Second Heart across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Second Heart is founded.
- Funding First funding round of $18.3M.
- Funding Latest funding round, Series C, of $14.7M.
Competitors of Second Heart
Second Heart has 3 listed competitors in our database, 3 of them funded. They include CVRx, HeartWare and Element Science.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cvrx.com | 2001 | Minneapolis, United States | $368.5M | 142 | Implantable technology for hypertension and heart failure is developed. | |
| heartware.com | 2005 | Framingham, United States | $12.38M | 547 | Miniaturized ventricular assist devices are developed for heart failure treatment. | |
| elementscience.com | 2013 | San Francisco, United States | $192.6M | Wearable patch defibrillators are developed for sudden cardiac arrest treatment. |
Detailed competitors of Second Heart
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Second Heart (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Second Heart
Complete news archive for Second Heart
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Second Heart
Second Heart was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Second Heart is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Jeff Donofrio is the CEO of Second Heart, as recorded in our data. They have also founded this company.
Second Heart is a funded company, having raised a total of $33.98M across 3 funding rounds to date. The company's 1st funding round was a Series B of $18.3M, raised on Dec 2016.
Second Heart was founded in 2015 in Salt Lake City, United States, within the medical device sector focused on cardiovascular care. A proprietary aortic stent pump technology is utilized to create a circulatory support platform, deployed through low-profile catheter-based methods. An initial temporary assist pump is targeted for acute decompensated heart failure patients and high-risk percutaneous coronary interventions. A subsequent wirelessly powered device is intended for chronic heart failure support.
Second Heart's top competitors include CVRx, Element Science and HeartWare.
Second Heart offers Whisper and Freedom.
Second Heart has 1 investor. Key investors include Patel Property Investments.
Second Heart operates through Second Heart Assist Inc.